|
TransWorldNews (press release), GA - 1 May 2008
AVANIR™s first commercialized product, docosanol 10% cream, (sold as Abreva by its marketing partner GlaxoSmithKline Consumer Healthcare in North America ...
|
|
|
|
|
Earthtimes (press release), UK - 8 May 2008
... cabinet staples, Abreva(R), Aquafresh(R), Sensodyne(R) and Tums(R), which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies. ...
|
|
|
|
|
Business Wire (press release), CA - 29 Apr 2008
The Company™s first commercialized product, Abreva, is marketed in North America by GlaxoSmithKline Consumer Healthcare and is the leading over-the-counter ...
|
|
|
|
|
Business Wire (press release), CA - 21 Apr 2008
The Company's first commercialized product, Abreva, is marketed in North America by GlaxoSmithKline Consumer Healthcare and is the leading over-the-counter ...
|
|
|
|
|
